KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • Abbott Laboratories' Profit After Tax fell 12.15% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 billion, marking a year-over-year increase of 14236.17%. This contributed to the annual value of $13.4 billion for FY2024, which is 13417.79% up from last year.
  • As of Q3 2025, Abbott Laboratories' Profit After Tax stood at $1.6 billion, which was down 12.15% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Profit After Tax ranged from a high of $9.2 billion in Q4 2024 and a low of $1.0 billion during Q4 2022
  • For the 5-year period, Abbott Laboratories' Profit After Tax averaged around $2.0 billion, with its median value being $1.6 billion (2023).
  • As far as peak fluctuations go, Abbott Laboratories' Profit After Tax plummeted by 4806.44% in 2022, and later surged by 47898.37% in 2024.
  • Abbott Laboratories' Profit After Tax (Quarter) stood at $2.0 billion in 2021, then tumbled by 48.06% to $1.0 billion in 2022, then soared by 54.31% to $1.6 billion in 2023, then soared by 478.98% to $9.2 billion in 2024, then tumbled by 82.19% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.8 billion for Q2 2025, and $1.3 billion during Q1 2025.